Nektar Therapeutics shares rise as Wall Street remains positive on product pipelineShares of biotechnology company Nektar Therapeutics Inc. jumped Wednesday as analysts brushed off the report of a fourth-quarter loss and focused instead on the company's pipeline of products. The stock rose $1.53, or 12 percent, to $14 ...

Earnings roundup: Cowen posts loss, Fresh Del Monte profit grows on strong pineapple salesAmong the earnings stories for Tuesday, March 2, from AP Financial News: _ Cowen Group said Tuesday its loss for the fourth quarter narrowed as investment losses at the financial services firm moderated. _ Fresh Del Monte ...